Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India and Japan. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.
Low
225.05
High
479.00
Low
368.60
High
395.00
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How Gujarat Themis Biosyn Limited stacks up against its Drug Manufacturers - Specialty & Generic peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | GUJTHEM Gujarat Themis Biosyn Limited | 382.20 | 1.39% | 85.43 | 4.47 | 4,974 | 4.87% | 2.03% | 479.00 / 225.05 |
| 2 | AARTIDRUGS Aarti Drugs Limited | 419.00 | 2.76% | 20.01 | 20.94 | 3,824 | 0.95% | 11.68% | 534.00 / 318.95 |
| 3 | AARTIPHARM Aarti Pharmalabs Limited | 980.00 | 2.75% | 44.50 | 22.02 | 8,854 | 16.95% | 12.68% | 1,002.40 / 585.00 |
| 4 | ABBOTINDIA Abbott India Limited | 26,850.00 | 1.01% | 35.33 | 759.88 | 57,033 | 0.75% | 16.87% | 30,655.00 / 25,135.00 |
| 5 | AHCL ANLON HEALTHCARE LIMITED | 32.86 | 4.97% | 13.55 | 2.42 | 1,746 | 116.33% | 261.10% | 37.24 / 10.37 |
| 6 | AJANTPHARM Ajanta Pharma Limited | 3,586.00 | 0.96% | 39.48 | 90.83 | 44,748 | 0.38% | 46.24% | 3,796.00 / 2,379.30 |
| 7 | AKUMS AKUMS DRUGS AND PHARMA L | 815.80 | 0.33% | 42.83 | 19.05 | 12,490 | 8.48% | 74.32% | 838.80 / 409.30 |
| 8 | ALIVUS Alivus Life Sciences Limited | 1,380.00 | 0.05% | 28.15 | 49.03 | 16,942 | 2.62% | 46.19% | 1,493.80 / 819.00 |
| 9 | ALKEM Alkem Laboratories Limited | 5,215.00 | 1.00% | 28.90 | 180.45 | 62,353 | 2.85% | 2.00% | 5,933.50 / 5,051.00 |
| 10 | AMRUTANJAN Amrutanjan Health Care Limited | 516.00 | 0.24% | 27.63 | 18.67 | 1,483 | 1.71% | 28.74% | 760.15 / 476.50 |
| 11 | APLLTD Alembic Pharmaceuticals Limited | 819.00 | 0.78% | 23.22 | 35.27 | 16,099 | 1.72% | 13.12% | 998.00 / 635.80 |
| 12 | ASTRAZEN AstraZeneca Pharma India Limited | 6,010.00 | 2.85% | 88.58 | 67.85 | 15,078 | 16.41% | 31.32% | 9,849.50 / 5,986.00 |
| 13 | AUROPHARMA Aurobindo Pharma Limited | 1,666.30 | 0.34% | 26.03 | 64.00 | 96,479 | 2.86% | 62.15% | 1,740.00 / 1,066.80 |